Q1 2025 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2025-05-15 · accession 0001389933-25-000002
$352.7M
Reported value
83
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $32.8M | 9.30% | 404,505 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $24.1M | 6.83% | 13,680,554 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $23.2M | 6.58% | 656,176 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $19.4M | 5.51% | 461,804 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $19.1M | 5.42% | 592,273 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $16.0M | 4.54% | 398,100 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $13.5M | 3.82% | 152,263 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $13.1M | 3.72% | 102,500 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $12.6M | 3.57% | 680,782 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $12.5M | 3.55% | 80,398 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $9.7M | 2.74% | 589,330 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $9.2M | 2.60% | 273,739 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $8.7M | 2.46% | 752,359 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $7.9M | 2.25% | 71,615 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $6.7M | 1.90% | 544,502 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $5.8M | 1.64% | 731,363 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $5.6M | 1.60% | 294,208 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $5.4M | 1.54% | 492,515 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $5.3M | 1.50% | 220,235 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.9M | 1.39% | 309,200 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $4.9M | 1.39% | 625,126 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $4.7M | 1.34% | 4,000,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $4.5M | 1.27% | 65,552 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.2M | 1.19% | 558,255 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $4.0M | 1.14% | 183,140 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $3.3M | 0.93% | 130,175 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $3.3M | 0.93% | 458,065 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $3.1M | 0.89% | 11,900 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $3.1M | 0.88% | 94,200 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $3.1M | 0.87% | 463,368 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $3.0M | 0.84% | 443,998 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.9M | 0.82% | 169,996 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $2.8M | 0.78% | 212,001 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $2.2M | 0.62% | 1,222,358 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $2.1M | 0.60% | 429,252 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $2.1M | 0.59% | 1,567,561 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $2.0M | 0.58% | 711,046 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $2.0M | 0.57% | 1,380,118 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $1.8M | 0.50% | 1,441,029 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $1.7M | 0.50% | 11,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $1.7M | 0.49% | 127,900 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.7M | 0.48% | 314,775 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.6M | 0.44% | 64,516 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $1.5M | 0.42% | 847,176 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $1.5M | 0.42% | 156,533 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $1.4M | 0.38% | 242,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.3M | 0.38% | 130,316 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $1.3M | 0.37% | 378,083 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.3M | 0.36% | 213,347 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC | $1.2M | 0.34% | 43,348 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $1.2M | 0.34% | 95,290 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $1.1M | 0.32% | 2,511,374 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.1M | 0.32% | 912,928 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.1M | 0.32% | 304,752 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $1.1M | 0.31% | 245,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.0M | 0.29% | 59,000 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $1.0M | 0.28% | 636,103 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $1.0M | 0.28% | 64,479 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $998,639 | 0.28% | 907,854 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $956,130 | 0.27% | 10,500 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $909,334 | 0.26% | 586,667 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $860,190 | 0.24% | 108,200 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $819,767 | 0.23% | 47,086 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $811,215 | 0.23% | 1,704,232 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $798,583 | 0.23% | 371,434 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $789,350 | 0.22% | 291,273 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $726,275 | 0.21% | 522,500 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $685,984 | 0.19% | 80,799 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $603,065 | 0.17% | 51,500 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $471,000 | 0.13% | 150,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $465,800 | 0.13% | 340,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $459,000 | 0.13% | 450,000 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $453,000 | 0.13% | 600,000 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $411,800 | 0.12% | 142,000 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $397,707 | 0.11% | 272,402 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $315,954 | 0.09% | 224,081 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $284,364 | 0.08% | 437,079 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $279,835 | 0.08% | 137,174 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $222,911 | 0.06% | 401,136 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $221,920 | 0.06% | 38,000 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $217,000 | 0.06% | 140,000 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $90,000 | 0.03% | 125,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $26,977 | 0.01% | 47,319 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.